Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

author_full_names

Sutanto, Samuel Theodorus (58054575100); Sinto, Robert (36099377100); Pasaribu, Adeline (57428543800); Shakinah, Sharifah (57428569400)

authors

Sutanto S.T.; Sinto R.; Pasaribu A.; Shakinah S.

title

Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19

source_title

Acta Medica Indonesiana

abstract

Coronavirus disease 2019 (COVID-19) is a respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the complexity of multimorbidity in Indonesia, it is crucial to find another line of antiviral for COVID-19. Th

author_keywords

antiviral; COVID-19; molnupiravir; nirmatrelvir/ritonavir; SARS-CoV-2

funding_texts

correspondence_address

R. Sinto; Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Jl. Diponegoro no. 71,, 10430, Indonesia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.

publisher

Indonesian Society of Internal Medicine

issn

01259326

pubmed_id

36624705

abbreviated_source_title

Acta Med Indones

authors_with_affiliations

Sutanto S.T., Faculty of Medicine, Universitas Kristen Krida Wacana, Jakarta, Indonesia; Sinto R., Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakar

affiliations

Faculty of Medicine, Universitas Kristen Krida Wacana, Jakarta, Indonesia; Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia

author_s_id

58054575100; 36099377100; 57428543800; 57428569400

cited_by

year

2022

link

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85145957296&partnerID=40&md5=45dd7d85b07e3138bb57d6c7276ba5d5

document_type

Review